Int J Angiol 1996; 5(4): 192-195
DOI: 10.1007/BF02044256
Original Articles

© Georg Thieme Verlag KG Stuttgart · New York

Is the captopril test suitable as a screening test for renovascular hypertension in a general hypertensive population?

Nen-Chung Chang, Zhi-Yang Lai, Chun-Hsiung Wang, Tze-Che Wang
  • Section of Cardiology, Department of Medicine, Taipei Medical College and Hospital, Taipei, Taiwan, Republic of China
Presented at the 36th Annual World Congress, International College of Angiology, New York, New York, July 1994
Further Information

Publication History

Publication Date:
22 April 2011 (online)


The goal of this study was to determine whether the captopril test is suitable as a screening tool for renovascular hypertension (RVH) in the primary care setting. Of the 100 consecutive patients with definite hypertension included in this prospective study, three (3%) were found to have RVH. The captopril test detected RVH with a 100% sensitivity, a 90% specificity, and a 23% positive predictive value by using the three combined criteria developed by the investigators at Cornell University. We conclude that the captopril test is a worthwhile screening test for RVH in an unselected, but well prepared, general hypertensive population with normal renal function.